Bioadvanced Science-based Solutions 3-in-1 Insect, Disease & Mite Control Ready-to-spray Instruction Guide

Bioadvanced Science-based Solutions 3-in-1 Insect, Disease & Mite Control Ready-to-spray Instruction Guide

SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE

COMPANY/UNDERTAKING

SECTION 2: HAZARDS IDENTIFICATION

Classification in accordance with regulation HCS 29CFR §1910.1200
Reproductive toxicity : Category 2

Signal word : Warning

Hazard statements
Suspected of damaging fertility or the unborn child.

Precautionary statements
Obtain special instructions before use.
Do not handle until all safety precautions have been read and understood.
Wear protective gloves/protective clothing/eye protection/face protection.
IF exposed or concerned: Get medical advice/attention.
Store locked up.
Dispose of contents/container in accordance with local regulation.

Other hazards
No other hazards known.

SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS

SECTION 4: FIRST AID MEASURES

Description of first aid measures

General advice
When possible, have the product container or label with you when calling a poison control center or doctor or going for treatment.

Inhalation
Move to fresh air. If person is not breathing, call 911 or an ambulance, then give artificial respiration, preferably mouth-to-mouth if possible. Call a physician or poison control center immediately.

Skin contact
Take off contaminated clothing and shoes immediately. Wash off immediately with plenty of water for at least 15 minutes. Call a physician or poison control center immediately.

Eye contact
Hold eye open and rinse slowly and gently with water for 15-20 minutes. Remove contact lenses, if present, after the first 5 minutes, then continue rinsing eye. Call a physician or poison control center immediately.

Ingestion
Call a physician or poison control center immediately. Rinse out mouth and give water in small sips to drink. DO NOT induce vomiting unless directed to do so by a physician or poison control center. Never give anything by mouth to an unconscious person. Do not leave victim unattended.

Most important symptoms and effects, both acute and delayed Symptoms
To date no symptoms are known.

Indication of any immediate medical attention and special treatment needed Treatment
Appropriate supportive and symptomatic treatment as indicated by the patient’s condition is recommended. There is no specific antidote

SECTION 5: FIREFIGHTING MEASURES

SECTION 6: ACCIDENTAL RELEASE MEASURES

SECTION 7: HANDLING AND STORAGE

SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION

Control parameters

Exposure controls

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

• Appearance   white to light beige
• Physical State   Liquid
• Odor   almost odourless
• Odour Threshold   no data available
• pH   >= 3 at 100 %
• Vapor Pressure   no data available
• Vapor Density (Air = 1)   no data available
• Density   ca. 1.03 g/cm³ at 20 °C
• Evapouration rate   no data available
• Boiling Point   no data available
• Melting / Freezing Point   no data available
• Water solubility   dispersible
• Minimum Ignition Energy   not applicable
• Decomposition temperature   no data available
• Partition coefficient: n-octanol/water    no data available
• Viscosity   100 – 500 mPa.s
• Flash point   > 93.4 °C
• Autoignition temperature   no data available
• Lower explosion limit no data available
• Upper explosion limit   no data available
• Explosivity   not applicable

SECTION 10: STABILITY AND REACTIVITY

• Reactivity Thermal decomposition
  no data available

• Chemical stability
  Stable under normal conditions.

• Possibility of hazardous reactions
  No dangerous reaction known under conditions of normal use.

• Conditions to avoid
  no data available

• Incompatible materials
  no data available

• Hazardous decomposition products
  No decomposition products expected under normal conditions of use.

SECTION 11: TOXICOLOGICAL INFORMATION

• Exposure routes
  Inhalation, Skin Absorption, Eye contact, Ingestion

• Immediate Effects Eye
  May cause mild irritation to eyes.

• Skin
  Harmful if absorbed through skin. May cause slight irritation.

• Ingestion
  Harmful if swallowed.

• Inhalation
  Harmful if inhaled.

• Information on toxicological effects

• Acute oral toxicity
  LD50 (female rat) > 2,000 mg/kg

• Acute inhalation toxicity
  LC50 (male/female combined rat) > 5.1 mg/l
  Exposure time: 4 h
  Determined in the form of a respirable aerosol.
  (actual)
  LC50 (male/female combined rat) > 20.4 mg/l
  Exposure time: 1 h
  Determined in the form of a respirable aerosol.
  Extrapolated from the 4 hr LC50.
  (actual)

• Acute dermal toxicity
  LD50 (male/female combined rat) > 4,000 mg/kg

• Skin irritation
  Slight irritation (rabbit)

• Eye irritation
  Minimally irritating. (rabbit)

• Sensitisation
  Non-sensitizing. (guinea pig)

Assessment repeated dose toxicity
Imidacloprid did not cause specific target organ toxicity in experimental animal studies.
Tau-fluvalinate did not cause specific target organ toxicity in experimental animal studies.
Tebuconazole did not cause specific target organ toxicity in experimental animal studies.

Assessment Mutagenicity
Imidacloprid was not mutagenic or genotoxic based on the overall weight of evidence in a battery of in vitro and in vivo tests.
Tau-fluvalinate was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.
Tebuconazole was not mutagenic or genotoxic in a battery of in vitro and in vivo tests.

Assessment Carcinogenicity
Imidacloprid was not carcinogenic in lifetime feeding studies in rats and mice.
Tau-fluvalinate was not carcinogenic in lifetime feeding studies in rats and mice.
Tebuconazole caused at high dose levels an increased incidence of tumours in mice in the following organ(s): liver. The mechanism of tumour formation is not considered to be relevant to man.

ACGIH
None.

NTP
None.

IARC
None.

OSHA
None.

Assessment toxicity to reproduction
Imidacloprid caused reproduction toxicity in a two-generation study in rats only at dose levels also toxic to the parent animals. The reproduction toxicity seen with Imidacloprid is related to parental toxicity. Tau- fluvalinate did not cause reproductive toxicity in a two-generation study in rats. Tebuconazole caused reproduction toxicity in a two-generation study in rats only at dose levels also toxic to the parent animals. The reproduction toxicity seen with Tebuconazole is related to parental toxicity.

Assessment developmental toxicity
Imidacloprid caused developmental toxicity only at dose levels toxic to the dams. The developmental effects seen with Imidacloprid are related to maternal toxicity. Tau-fluvalinate did not cause developmental toxicity in rats and rabbits. Tebuconazole caused developmental toxicity only at dose levels toxic to the dams. Tebuconazole caused an increased incidence of post implantation losses, an increased incidence of non-specific malformations.

Further information
Only acute toxicity studies have been performed on the formulated product.
The non-acute information pertains to the active ingredient(s).

SECTION 12: ECOLOGICAL INFORMATION

SECTION 13: DISPOSAL CONSIDERATIONS

Waste treatment methods Product
It is best to use all of the product in accordance with label directions. If it is necessary to dispose of unused product, please follow container label instructions and applicable local guidelines. Never place unused product down any indoor or outdoor drain.

Contaminated packaging
Do not re-use empty containers. Place empty container in trash.

RCRA Information
Characterization and proper disposal of this material as a special or hazardous waste is dependent upon Federal, State and local laws and are the user’s responsibility. RCRA classification may apply.

SECTION 14: TRANSPORT INFORMATION

SECTION 15: REGULATORY INFORMATION

SECTION 16: OTHER INFORMATION

Bioadvanced Science-based Solutions 3-in-1 Insect, Disease & Mite Control Ready-to-spray Instruction Guide – Optimized PDF
Bioadvanced Science-based Solutions 3-in-1 Insect, Disease & Mite Control Ready-to-spray Instruction Guide – Original PDF

Read User Manual Online (PDF format)

Read User Manual Online (PDF format)  >>

Download This Manual (PDF format)

Download this manual  >>